Back
Champion Homes Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
51
SKY
Champion Homes
Last Price:
90.84
Seasonality Move:
5.85%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
128.41
Seasonality Move:
9.41%
Buy
51
Champion Homes (SKY)
is a Buy
Is Champion Homes a Buy, Sell or Hold?
- The current Champion Homes [SKY] share price is $90.82. The Score for SKY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- SKY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.42. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKY Stock Price Chart
What is Champion Homes's stock price today?
-
The Champion Homes share price today is $90.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKY is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SKY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 42.72 | Sell |
Chaikin Money Flow: | -223471 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.41 - 96.31) | Sell |
Bollinger Bands (100): | (72.01 - 92.97) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 57.01 | Buy |
Chaikin Money Flow: | 461520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.97 - 126.81) | Buy |
Bollinger Bands (100): | (122.4 - 147.1) | Sell |
SKY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.17 | Sell |
20-day SMA: | 94.55 | Sell |
50-day SMA: | 92 | Sell |
200-day SMA: | 80.02 | Buy |
8-day EMA: | 94.75 | Sell |
20-day EMA: | 94.29 | Sell |
50-day EMA: | 90.91 | Sell |
200-day EMA: | 80.76 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.47 | Buy |
20-day SMA: | 123.38 | Buy |
50-day SMA: | 128.91 | Sell |
200-day SMA: | 129.86 | Sell |
8-day EMA: | 125.64 | Buy |
20-day EMA: | 124.89 | Buy |
50-day EMA: | 128.25 | Buy |
200-day EMA: | 127.82 | Buy |
Champion Homes Earnings Growth & SKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.75 per share, and an increase next year of $0.07 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.27 per share, and an increase next year of $8.99 per share.
Champion Homes Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |